Back to Search
Start Over
Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell response.
- Source :
- Epigenomics; May2024, Vol. 16 Issue 9, p653-670, 18p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 17501911
- Volume :
- 16
- Issue :
- 9
- Database :
- Complementary Index
- Journal :
- Epigenomics
- Publication Type :
- Academic Journal
- Accession number :
- 177469376
- Full Text :
- https://doi.org/10.2217/epi-2023-0374